Skip to main content
KROS logo

KROS · Keros Therapeutics, Inc. · Holdings

Track KROS — free
$11.95 +0.31 (+2.66%) At close · Oct 9
Market Cap
$236.93M
Shares
19.83M
Volume · Oct 9 194.39K Avg daily vol (3M) 194.1K

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Institutional holdings are being reconciled with SEC filings. Holder totals and changes may be incomplete until reconciliation finishes.
The Sep 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out. Each fund's Change is measured against its own previous reported quarter, shown in the Reported column. Pick a completed quarter in the Quarter selector below to put every fund on one quarter and see the stock-wide activity breakdown.
Holders: 132
Total Value: $198,683,058
Total Shares: 18,568,505
Showing 1–100 of 133 holdings by value · page 1 of 2

Institutional Ownership Trend

26 quarters

Holder Concentration

Across 132 13F filers
Top Holder
15.0%
Sep 2023 → Jun 2026 · range 10.1% – 15.9%
of institutional value
Top 5
36.4%
Sep 2023 → Jun 2026 · range 32.2% – 43.9%
of institutional value
Top 10
53.8%
Sep 2023 → Jun 2026 · range 50.2% – 65.7%
of institutional value
HHI
473
Sep 2023 → Jun 2026 · range 395 – 597
Broadly held
Showing 100 of 133
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1664710 CUSIP 492327101 13F (30d) 4 filings 4 filers Visit website Investor relations